Cero Therapeutics- FDA Said Clinical Hold Has Been Placed Due to Insufficient Data Given for Two Issues Within Pharmacology and Toxicology of CER-1236
Cero Therapeutics - FDA表示,由於CER-1236在藥理學和毒理學方面存在兩個問題的數據不足,因此已經實施臨床暫停。
Cero Therapeutics- FDA Said Clinical Hold Has Been Placed Due to Insufficient Data Given for Two Issues Within Pharmacology and Toxicology of CER-1236
Cero Therapeutics - FDA表示,由於CER-1236在藥理學和毒理學方面存在兩個問題的數據不足,因此已經實施臨床暫停。
譯文內容由第三人軟體翻譯。